For instance, necrotizing pneumonia similar to our case has been reported in a 61-year-old man with severe asthma receiving dupilumab, an anti-IL-4/IL-13 monoclonal antibody, who developed bilateral cavitary lesions confirmed on computed tomography. This evidence concerns the gene IL13 and asthma.